ReviewDer Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete2014
[Therapy of hypertrophic scars and keloids].
Review in Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Topical cryoanesthesia for the relief of pain caused by steroid injections used to treat hypertrophic scars and keloids.Medicine · 2017Trial
- [Atypical keloids with an unusual myofibroblastic differentiation in a patient with acne vulgaris].Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete · 2022Article
- Loureirin A Exerts Antikeloid Activity by Antagonizing the TGF-Evidence-based complementary and alternative medicine : eCAM · 2022Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Keloids mostly occur between the ages of 10 and 30 years and grow continuously beyond the original margins of the scar. Beside the cosmetic impairment they often lead to pruritus, pain, contractures and decrease in quality of life. Advances in the understanding of the genetics and pathogenesis of hypertrophic scars and keloids have led to new therapeutic options. Nevertheless treatment remains a challenge and there is no single treatment modality which is appropriate for all types of scars. Combined approaches are becoming more widely employed as they are more effective than single treatment modalities. This article gives an overview of hypertrophic scars and keloids, their pathogenesis and recommended therapeutic approaches.
Indexed as
Identifiers
25412721What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.